BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marson CM. Targeting the Histamine H 4 Receptor. Chem Rev 2011;111:7121-56. [DOI: 10.1021/cr900166w] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Łażewska D, Więcek M, Ner J, Kamińska K, Kottke T, Schwed JS, Zygmunt M, Karcz T, Olejarz A, Kuder K, Latacz G, Grosicki M, Sapa J, Karolak-wojciechowska J, Stark H, Kieć-kononowicz K. Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands. European Journal of Medicinal Chemistry 2014;83:534-46. [DOI: 10.1016/j.ejmech.2014.06.032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
2 Gao L, Schwed JS, Weizel L, De Jonghe S, Stark H, Herdewijn P. Synthesis and evaluation of novel ligands for the histamine H4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold. Bioorganic & Medicinal Chemistry Letters 2013;23:132-7. [DOI: 10.1016/j.bmcl.2012.10.139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
3 Cíž M, Lojek A. Modulation of neutrophil oxidative burst via histamine receptors. Br J Pharmacol 2013;170:17-22. [PMID: 23336732 DOI: 10.1111/bph.12107] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
4 Roy N, Levanon S, Asbell PA. Potential Biomarkers for Allergic Conjunctival Diseases. Eye Contact Lens 2020;46 Suppl 2:S109-21. [PMID: 32097185 DOI: 10.1097/ICL.0000000000000688] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Andaloussi M, Lim HD, van der Meer T, Sijm M, Poulie CB, de Esch IJ, Leurs R, Smits RA. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787. Bioorganic & Medicinal Chemistry Letters 2013;23:2663-70. [DOI: 10.1016/j.bmcl.2013.02.091] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
6 He GH, Ding JQ, Zhang X, Xu WM, Lin XQ, Huang MJ, Feng J, Wang P, Cai WK. Activation of histamine H4 receptor suppresses the proliferation and invasion of esophageal squamous cell carcinoma via both metabolism and non-metabolism signaling pathways. J Mol Med (Berl) 2018;96:951-64. [PMID: 30058054 DOI: 10.1007/s00109-018-1676-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Naporra F, Gobleder S, Wittmann HJ, Spindler J, Bodensteiner M, Bernhardt G, Hübner H, Gmeiner P, Elz S, Strasser A. Dibenzo[b,f][1,4]oxazepines and dibenzo[b,e]oxepines: Influence of the chlorine substitution pattern on the pharmacology at the H1R, H4R, 5-HT2AR and other selected GPCRs. Pharmacol Res 2016;113:610-25. [PMID: 27697645 DOI: 10.1016/j.phrs.2016.09.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tichenor MS, Thurmond RL, Venable JD, Savall BM. Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators. J Med Chem 2015;58:7119-27. [PMID: 25993395 DOI: 10.1021/acs.jmedchem.5b00516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
9 Chigbu DI, Coyne AM. Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. Clin Ophthalmol 2015;9:1215-25. [PMID: 26185412 DOI: 10.2147/OPTH.S63790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
10 Wifling D, Löffel K, Nordemann U, Strasser A, Bernhardt G, Dove S, Seifert R, Buschauer A. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants. Br J Pharmacol 2015;172:785-98. [PMID: 24903527 DOI: 10.1111/bph.12801] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kiss R, Keserű GM. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 2012;22:205-21. [PMID: 22385042 DOI: 10.1517/13543776.2012.665447] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
12 Hammer SG, Gobleder S, Naporra F, Wittmann HJ, Elz S, Heinrich MR, Strasser A. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity. Bioorg Med Chem Lett 2016;26:292-300. [PMID: 26718844 DOI: 10.1016/j.bmcl.2015.12.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
13 Belen’kii LI, Evdokimenkova YB. The Literature of Heterocyclic Chemistry, Part XII, 2010–2011. Elsevier; 2014. pp. 147-274. [DOI: 10.1016/b978-0-12-420160-6.00004-5] [Cited by in Crossref: 13] [Article Influence: 1.6] [Reference Citation Analysis]
14 Hwang H. Pathogenesis of allergic conjunctivitis and trends in its treatment. J Korean Med Assoc 2017;60:251. [DOI: 10.5124/jkma.2017.60.3.251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Darras FH, Pockes S, Huang G, Wehle S, Strasser A, Wittmann HJ, Nimczick M, Sotriffer CA, Decker M. Synthesis, biological evaluation, and computational studies of Tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists. ACS Chem Neurosci 2014;5:225-42. [PMID: 24422467 DOI: 10.1021/cn4002126] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
16 Labeeuw O, Levoin N, Billot X, Danvy D, Calmels T, Krief S, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M. Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists. Bioorg Med Chem Lett 2016;26:5263-6. [PMID: 27692832 DOI: 10.1016/j.bmcl.2016.09.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Yokoyama S, Hiramoto K, Koyama M, Ooi K. Skin disruption is associated with indomethacin-induced small intestinal injury in mice. Exp Dermatol 2014;23:659-63. [PMID: 25041031 DOI: 10.1111/exd.12499] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bodensteiner J, Baumeister P, Geyer R, Buschauer A, Reiser O. Synthesis and pharmacological characterization of new tetrahydrofuran based compounds as conformationally constrained histamine receptor ligands. Org Biomol Chem 2013;11:4040. [DOI: 10.1039/c3ob40441b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Feliszek M, Speckmann V, Schacht D, von Lehe M, Stark H, Schlicker E. A search for functional histamine H4 receptors in the human, guinea pig and mouse brain. Naunyn Schmiedebergs Arch Pharmacol 2015;388:11-7. [PMID: 25300787 DOI: 10.1007/s00210-014-1053-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
20 Levoin N, Labeeuw O, Billot X, Calmels T, Danvy D, Krief S, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. Eur J Med Chem 2017;125:565-72. [PMID: 27718472 DOI: 10.1016/j.ejmech.2016.09.074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
21 Labib BA, Chigbu DI. Therapeutic Targets in Allergic Conjunctivitis. Pharmaceuticals 2022;15:547. [DOI: 10.3390/ph15050547] [Reference Citation Analysis]
22 Wagner E, Wittmann H, Elz S, Strasser A. Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor—H1/H4 receptor selectivity. Naunyn-Schmiedeberg's Arch Pharmacol 2014;387:235-50. [DOI: 10.1007/s00210-013-0926-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
23 Utepova IA, Trestsova MA, Chupakhin ON, Charushin VN, Rempel AA. Aerobic oxidative C–H/C–H coupling of azaaromatics with indoles and pyrroles in the presence of TiO 2 as a photocatalyst. Green Chem 2015;17:4401-10. [DOI: 10.1039/c5gc00753d] [Cited by in Crossref: 42] [Article Influence: 6.0] [Reference Citation Analysis]
24 Corrêa MF, dos Santos Fernandes JP. Histamine H4 receptor ligands: future applications and state of art. Chem Biol Drug Des 2015;85:461-80. [PMID: 25228262 DOI: 10.1111/cbdd.12431] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
25 Suwa E, Yamaura K, Sato S, Ueno K. Increased expression of the histamine H4 receptor following differentiation and mediation of the H4 receptor on interleukin-8 mRNA expression in HaCaT keratinocytes. Exp Dermatol 2014;23:138-40. [PMID: 24372819 DOI: 10.1111/exd.12313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Petri D, Schlicker E. A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptors. Neuropharmacology 2016;106:129-34. [PMID: 26211976 DOI: 10.1016/j.neuropharm.2015.06.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Yamaura K, Shigemori A, Suwa E, Ueno K. Expression of the histamine H4 receptor in dermal and articular tissues. Life Sci 2013;92:108-13. [PMID: 23154242 DOI: 10.1016/j.lfs.2012.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
28 Li S, Ding M, Wu Y, Xue S, Ji Y, Zhang P, Zhang Z, Cao Z, Zhang F. Histamine Sensitization of the Voltage-Gated Sodium Channel Nav1.7 Contributes to Histaminergic Itch in Mice. ACS Chem Neurosci 2022. [PMID: 35157443 DOI: 10.1021/acschemneuro.2c00012] [Reference Citation Analysis]
29 Abdel-megeed MF, El-hiti GA, Badr BE, Azaam MM. Synthesis of a Series of Diphenyl (Arylamino)(Pyridin-3-yl)Methylphosphonates as Potential Antimicrobial Agents. Phosphorus, Sulfur, and Silicon and the Related Elements 2013;188:879-85. [DOI: 10.1080/10426507.2012.717141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Seifert R. Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells. Biochem Pharmacol 2013;86:853-61. [PMID: 23933388 DOI: 10.1016/j.bcp.2013.07.029] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
31 Latacz G, Kechagioglou P, Papi R, Łażewska D, Więcek M, Kamińska K, Wencel P, Karcz T, Schwed JS, Stark H, Kyriakidis DA, Kieć-kononowicz K. The Synthesis of 1,3,5-triazine Derivatives and JNJ7777120 Analogues with Histamine H 4 Receptor Affinity and Their Interaction with PTEN Promoter. Chem Biol Drug Des 2016;88:254-63. [DOI: 10.1111/cbdd.12752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
32 Geyer R, Nordemann U, Strasser A, Wittmann HJ, Buschauer A. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists. J Med Chem 2016;59:3452-70. [PMID: 27007611 DOI: 10.1021/acs.jmedchem.6b00120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Sarasola MP, Táquez Delgado MA, Nicoud MB, Medina VA. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 2021;9:e00778. [PMID: 34609067 DOI: 10.1002/prp2.778] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Martens SJ, Geiger DK. Structural characterization of two tetra-chlorido-zincate salts of 4-carb-oxy-1H-imidazol-3-ium: a salt hydrate and a co-crystal salt hydrate. Acta Crystallogr E Crystallogr Commun 2017;73:162-7. [PMID: 28217334 DOI: 10.1107/S2056989017000317] [Reference Citation Analysis]
35 Savych I, Ejaz SA, Shah SJA, Iaroshenko VO, Villinger A, Sosnovskikh VY, Iqbal J, Abbasi A, Langer P. Reactions of 3-Acylchromones with Heterocyclic Ketene Aminals: One-Pot Synthesis and Phosphatase Inhibitory Activity of Fused Pyridine Derivatives: Reactions of 3-Acylchromones with Heterocyclic Ketene Aminals: One-Pot Synthesis and Phosphatase Inhibitory Activity of Fused Pyridine Derivatives. Eur J Org Chem 2017;2017:186-202. [DOI: 10.1002/ejoc.201601138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
36 Vardanyan R, Hruby V. Antihistamine Drugs. Synthesis of Best-Seller Drugs. Elsevier; 2016. pp. 247-63. [DOI: 10.1016/b978-0-12-411492-0.00016-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Singh J, Shah R, Singh D. Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. Int Immunopharmacol 2016;40:362-84. [PMID: 27694038 DOI: 10.1016/j.intimp.2016.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
38 Domínguez‐álvarez E, Łażewska D, Szabó Z, Hagenow S, Reiner D, Gajdács M, Spengler G, Stark H, Handzlik J, Kieć‐kononowicz K. The Search for Histamine H 4 Receptor Ligands with Anticancer Activity among Novel (Thio)urea Derivatives. ChemistrySelect 2019;4:10943-52. [DOI: 10.1002/slct.201902747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Mirzahosseini A, Dalmadi B, Csutora P. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells. Cell Immunol 2013;283:38-44. [PMID: 23850674 DOI: 10.1016/j.cellimm.2013.05.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]